ArticleFrontiers in pharmacology2021

Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction.

Jinhao Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.